TENB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TENB is not a good buy right now for an impatient investor. The prevailing trend is still bearish (SMA200 > SMA20 > SMA5), momentum is weak (RSI 41), and pattern-based stats point to slightly negative near-term drift into earnings (2/4). While options positioning is notably call-skewed (bullish sentiment), it is not yet translating into a clean technical uptrend. I would avoid new long entries here and prefer to sell/step aside until price reclaims key resistance (23.09+) with improving momentum.
Trend/structure: Bearish moving-average stack (SMA200 > SMA20 > SMA5) signals the primary trend remains down. Momentum: MACD histogram is positive (0.0561) but positively contracting—suggesting upside momentum is fading rather than accelerating. RSI(6)=41.61 is neutral-to-weak, consistent with a soft tape and limited buying pressure. Key levels: Pivot 22.307 is near current price (22.06), implying indecision at an inflection. Support levels: S1 21.522 then S2 21.037 (breaks likely invite continuation selling). Resistance: R1 23.092 then R2 23.577 (needs reclaim for a trend change). Near-term bias: With price below pivot and bearish MA stack intact, probability favors chop-to-down unless buyers quickly push and hold above ~23.09.
Options market is strongly call-skewed (bullish positioning).
Cybersecurity demand commentary in analyst notes remains generally constructive on industry fundamentals (security + AI initiatives).
Earnings catalyst upcoming: QDEC 2025 earnings on 2026-02-04 after hours (potential upside if guidance/metrics surprise positively, especially if they clarify the billing transition / Tenable One disclosures).
Technical trend is still bearish (SMA200 > SMA20 > SMA
and momentum is not improving convincingly (MACD contracting, RSI weak).
Pattern-based forward odds are slightly negative: ~70% chance of -0.46% next day and -1.6% next week, suggesting downside drift risk.
Earnings proximity (2026-02-
can amplify downside if guidance disappoints, especially given elevated IV.
No supportive news flow in the last week—no fresh catalyst to reverse the chart immediately.
Billing transition (multi-year to annual upfront) is creating volatility in reported growth metrics (cRPO vs billings), which can keep pressure on sentiment and valuation until clearer targets are provided.
Latest quarter: 2025/Q3. Growth: Revenue rose to $252.44M (+11.16% YoY), indicating continued top-line growth. Profitability: Net income fell to $2.26M (-124.54% YoY) and EPS dropped to $0.02 (-125% YoY), signaling meaningful deterioration in bottom-line performance versus last year. Margins: Gross margin was 77.52% (down ~0.31pp YoY), still high for software but slightly compressing. Takeaway: Solid revenue growth, but earnings power weakened materially—this makes the stock more dependent on future execution and guidance to re-rate upward.
Recent trend: Multiple firms cut price targets in early Jan 2026 (and late 2025) while generally maintaining their ratings—net message is: long-term constructive but near-term expectations/valuation reset. Key changes:
